Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice release_477tyhloc5b7dfppwwp5s6rtzi

by Ying Ann Chiao, Huiliang Zhang, Mariya Sweetwyne, Jeremy Whitson, Ying Sonia Ting, Nathan Basisty, Lindsay K Pino, Ellen Quarles, Ngoc-Han Nguyen, Matthew D Campbell, Tong Zhang, Matthew J Gaffrey (+10 others)

Published in eLife by eLife Sciences Publications, Ltd.



Diastolic dysfunction is a prominent feature of cardiac aging in both mice and humans. We show here that 8-week treatment of old mice with the mitochondrial targeted peptide SS-31 (elamipretide) can substantially reverse this deficit. SS-31 normalized the increase in proton leak and reduced mitochondrial ROS in cardiomyocytes from old mice, accompanied by reduced protein oxidation and a shift towards a more reduced protein thiol redox state in old hearts. Improved diastolic function was concordant with increased phosphorylation of cMyBP-C Ser282 but was independent of titin isoform shift. Late-life viral expression of mitochondrial-targeted catalase (mCAT) produced similar functional benefits in old mice and SS-31 did not improve cardiac function of old mCAT mice, implicating normalizing mitochondrial oxidative stress as an overlapping mechanism. These results demonstrate that pre-existing cardiac aging phenotypes can be reversed by targeting mitochondrial dysfunction and implicate mitochondrial energetics and redox signaling as therapeutic targets for cardiac aging.
In application/xml+jats format

Archived Files and Locations

application/pdf  13.8 MB
file_4oe2sitfmvbzxd5ayoobaczpwe (publisher) (webarchive)
Read Archived PDF
Type  article-journal
Stage   published
Date   2020-07-10
Language   en ?
Container Metadata
Open Access Publication
In Keepers Registery
ISSN-L:  2050-084X
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 08e17a91-0df0-4cb5-a594-fda980607244